论文部分内容阅读
对我科1989年12月至1994年9月收治的40例合并上腔静脉综合征的癌瘤病人作一临床分析.其中肺癌病人29例占73%,恶性淋巴瘤7例占18%,纵隔转移癌4例占10%.治疗全部采用抗肿瘤药物的化学治疗(以下简称化疗)和内科对症处理,有效率88%,尤其对小细胞肺癌和恶性淋巴瘤有效率高达100%.资料显示用化疗加内科对症处理治疗由恶性肿瘤引起的上腔静脉综合征(SVCS)疗效高、见效快,无明显的毒副作用,不失为一种首选的治疗手段.
A clinical analysis of 40 patients with cancer associated with superior vena cava syndrome treated in our department from December 1989 to September 1994 was performed. Among them, 29 patients were diagnosed as having lung cancer, 73% were malignant tumors, 7 were malignant lymphomas, and 18% were mediastinal. Metastatic cancer was found in 4 patients, accounting for 10%. The treatment was performed with chemotherapy for antitumor drugs (chemotherapy) and medical symptomatic treatment. The effective rate was 88%, and the effective rate was 100% for small cell lung cancer and malignant lymphoma. Chemotherapy and internal medicine symptomatic treatment of upper vena cava syndrome (SVCS) caused by malignant tumors has high efficacy, quick response, no obvious toxic and side effects, it is a preferred treatment.